<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>nx8k223.htm
<DESCRIPTION>PFIZER INC. FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE> Pfizer Inc. 8-K </TITLE>

<BODY bgColor=#ffffff>
<DIV align=right> </DIV>
<P align=center><STRONG>UNITED STATES</STRONG></P>
<P align=center><STRONG><FONT size=4>SECURITIES AND EXCHANGE COMMISSION</FONT></STRONG></P>
<P align=center><STRONG>Washington, D.C. 20549</STRONG></P>
<P align=center><strong><br>FORM 8-K</strong><br></P>
<P align=center><strong>CURRENT REPORT</strong></P>
<P align=center><strong>Pursuant to Section 13 or 15(d) of the</strong><BR>
  <strong>Securities Exchange Act of 1934</strong></P>
<P align=center>Date of Report (Date of earliest event reported): <strong>February 23, 2017</strong></P>
<P align=center><STRONG>PFIZER INC.</STRONG><BR>
  (Exact name of registrant as specified in its charter)</P>
<TABLE width="87%" border=0>
  <TR>
    <TD width="43%">
      <DIV align=center><STRONG>Delaware</STRONG></DIV>
    </TD>
    <TD width="25%">
      <DIV align=center><STRONG>1-3619</STRONG></DIV>
    </TD>
    <TD width="32%">
      <DIV align=center><STRONG>13-5315170</STRONG></DIV>
    </TD>
  </TR>
  <TR>
    <TD width="43%">
      <DIV align=center>(State or other jurisdiction of incorporation)</DIV>
    </TD>
    <TD width="25%">
      <DIV align=center>(Commission File Number)</DIV>
    </TD>
    <TD width="32%">
      <DIV align=center>(I.R.S. Employer Identification No.)</DIV>
    </TD>
  </TR>
  <TR>
    <TD width="43%">
      <BLOCKQUOTE>
        <P align=center><STRONG>235 East 42nd Street <BR>
          New York, New York<BR>
          </STRONG>(Address of principal executive offices)<STRONG><BR>
          </STRONG></P>
      </BLOCKQUOTE>
    </TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="32%">
      <DIV align=center><STRONG>10017</STRONG><BR>
        (Zip Code)</DIV>
    </TD>
  </TR>
</TABLE>
<BLOCKQUOTE>
  <BLOCKQUOTE>
    <P align=center> Registrant's telephone number, including area code:
    <strong>&nbsp;(212) 733-2323</strong>&nbsp;
      <DIV align=center> <strong><br>
      </strong><u>Not Applicable</u>	<br>
      (Former Name or Former Address, if changed since last report)<br>
    </DIV>
  </BLOCKQUOTE>
</BLOCKQUOTE>
<P align=left>Check the appropriate box below if the Form 8-K filing is intended
  to simultaneously satisfy the obligation of the registrant under any of the
  following provisions (see General Instruction A.2. below): </P>
<P> [&nbsp; &nbsp;] Written communication pursuant to Rule 425 under the Securities
  Act (17 CFR 230.425)</P>
<P> [&nbsp; &nbsp;] Soliciting material pursuant to Rule 14a-12 under the Exchange
  Act (17 CFR 240.14a-12)</P>
<P> [&nbsp; &nbsp;] Pre-commencement communications pursuant to Rule 14d-2(b)
  under the Exchange Act (17 CFR 240.14d-2(b))</P>
<P> [ &nbsp;&nbsp;] Pre-commencement communications pursuant to Rule 13e-4(c)
  under the Exchange Act (17 CFR 240.13e-4(c))</P>
<table style="width: 100%">
	<tr>
		<td style="width: 112px">&nbsp;</td>
		<td>&nbsp;</td>
	</tr>
</table>
<table width="87%" border=0 height="217">
  <tr>
    <td style="width: 11%; height: 44" class="auto-style1" valign="top">
	<p><b>Item 5.02<br></b></p>
	  </td>
    <td width="87%" style="height: 44" valign="top">
	<p class="auto-style2" style="height: 45px"><strong>Departure of Directors or Certain Officers; Election  of Directors; Appointment of Certain Officers; Compensatory Arrangements of  Certain Officers<br></strong></p></td>
    <td width="87%" style="height: 44px">&nbsp;</td>
  </tr>
  <tr>
    <td height="145" colspan="2">
    <p><br><br>On February 23, 2017, the  Board of Directors of Pfizer Inc. (the &quot;Company&quot;) elected
	Ronald E. Blaylock to serve as a member of the Company's Board of Directors, effective immediately. In  addition, he was elected to the
	Corporate Governance Committee and the Science and Technology Committee of the Board.<br>
	</p>
    <p>Mr. Blaylock has been provided an indemnification  agreement and will receive compensation in accordance with the Company's  standard arrangements for non-employee directors.</p>
The press release, dated February 23, 2017,  announcing the election of Mr.
	Blaylock is attached hereto as Exhibit 99.1 and is incorporated herein  by reference.</td>
    <td height="145">
    &nbsp;</td>
  </tr>
</table>
<p>&nbsp;</p>
<table width="80%" border=0>
  <tr>
    <td width="21%"><strong>Item 9.01</strong></td>
    <td width="75%"><strong> Financial Statements and Exhibits.</strong></td>
    <td width="4%">&nbsp;</td>
  </tr>
</table>
<table width="80%" border=0>
  <tr>
    <td width="24%">(d) Exhibits<br></td>
    <td width="71%">&nbsp;</td>
    <td width="5%">&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td><u>Exhibit No.</u></td>
    <td><u>Description</u></td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>99.1</td>
    <td> Press Release of the Company, dated February 23, 2017</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td width="24%">&nbsp;</td>
    <td width="71%">&nbsp;</td>
    <td width="5%">&nbsp;</td>
  </tr>
</table>
<p align="left">&nbsp;</p>
<p align="center"><STRONG>SIGNATURE</STRONG></p>
<P>Under the requirements of the Securities Exchange Act of 1934, the registrant
  has caused this report to be signed on its behalf by the authorized undersigned.</P>
<TABLE width="82%" border=0>
  <TR>
    <TD width="33%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="61%">
      <DIV align=left>PFIZER INC.</DIV>
    </TD>
  </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp; </TD>
  </TR>
  <TR>
    <TD height=41>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
      <DIV align=left>By: <U>/s/ &nbsp;Margaret M. Madden</U><BR>
        Margaret M. Madden</DIV>
    </TD>
  </TR>
  <TR>
    <TD>Dated: February 23, 2017</TD>
    <TD>&nbsp;</TD>
    <TD>
      <DIV>Title: &nbsp;&nbsp;Senior Vice President and Corporate Secretary<br>
		  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Governance Counsel<br>
    </DIV></TD>
  </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
  </TR>
</TABLE>
<p>&nbsp;</p>
<BLOCKQUOTE>
  <BLOCKQUOTE>
    <BLOCKQUOTE>
      <BLOCKQUOTE>
        <BLOCKQUOTE>
          <BLOCKQUOTE>
            <BLOCKQUOTE>&nbsp;</BLOCKQUOTE>
          </BLOCKQUOTE>
          <p><b>EXHIBIT INDEX</b></p>
        </BLOCKQUOTE>
      </BLOCKQUOTE>
    </BLOCKQUOTE>
  </BLOCKQUOTE>
</BLOCKQUOTE>
<table width="81%" border=0>
  <tr>
    <td width="17%">
      <p><b>Number</b></p>
    </td>
    <td width="83%"><b>Description</b></td>
  </tr>
  <tr>
    <td width="17%">99.1</td>
    <td width="83%"> Press Release of the Company, dated February 23, 2017</td>
  </tr>
</table>
<P align=center>&nbsp;</P>
</TEXT>
</DOCUMENT>